Brief: Bergenbio Q4 Operating Loss NOK 33.5 Mln
26/02/2025 06:11
Feb 26 (Reuters) - Bergenbio ASA BGBIO.OL: Q4 OPERATING LOSS NOK 33.5 MILLION Source text: ID:nWkr4PvLLq Further company coverage: BGBIO.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Oncoinvent ASA
See all newsBrief: Oncoinvent To Raise Up To NOK 140 Million In Private Placement
Brief: Oncoinvent H1 Operating Loss NOK 69 Mln
Brief: Oncoinvent Secures New Patent Expanding Protection For Radspherin
Brief: Oncoinvent's Shares To Be Consolidated In Ratio Of 100:1
Brief: Oncoinvent To Increase Share Capital In Connection With Settlement Of Underwriting Fee